INTERRELATION OF KIMOKINE BIOMARKER LEVELS WITH CLINICAL PARAMETERS IN PARKINSON'S DISEASE AND PARKINSONISM “PLUS” SYNDROMES

Гульнара Саттаровна Рахимбаева, Дилшодахон Турдикуловна Акрамова

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research · 2025-yil

Annotatsiya

This article analyzes the relationship between monocyte-attracting chemical protein-1 (CCL2) levels and clinical indicators in Parkinson's disease and parkinsonism plus syndromes. Serum protein levels were compared with motor, cognitive, and stage changes. According to the study results, the level of this protein in parkinsonism plus syndromes was significantly higher and correlated significantly with Hoehn & Yahr, UPDRS, and MMSE indicators. These results indicate the possibility of using chemical protein-1, which attracts monocytes, as a useful biomarkers in differential diagnosis, prognosis, and assessment of the severity of the disease.

Maqola ma’lumotlari
MualliflarГульнара Саттаровна Рахимбаева, Дилшодахон Турдикуловна Акрамова
JurnalЖурнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research
Nashr sanasi2025-09-12
Jild6
Son5
TilO‘zbek

Kalit so‘zlar

болезнь Паркинсона, паркинсонизм-плюс, моноцитарный хемоаттрактантный белок-1, воспаление, биомаркер, когнитивные нарушения, моторная функция, Parkinson's disease, parkinsonism plus, monocyte-attracting chemical protein-1, inflammation, biomarkers, cognitive impairment, motor function, Паркинсон касаллиги, паркинсонизм плюс, моноцитларни жалб қилувчи кимёвий оқсил-1, яллиғланиш, биомаркер, когнитив бузилиш, мотор функция

Ilmiy soha

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research jurnalidan boshqa maqolalar

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research — barcha maqolalar